Abstract Objective To evaluate the efficacy and safety of the WT-2009 chemotherapy protocol for Wilms' tumor (WT) in children. Methods The clinical data of 34 children with newly-diagnosed WT between July 2009 and December 2013 were retrospectively analyzed. Among the 34 children, 2 died before treatment, 6 children did not accept therapy and 26 accepted the chemotherapy based on the WT-2009 chemotherapy protocol. Kaplan-Meier method was used to estimate the 2-year survival rate. Results The pathological analysis revealed the favorable histology WT was common (88%, 30/34). The most common first manifestation was abdominal masses (56%, 19/34). Among the 26 patients who accepted the chemotherapy based on the WT-2009 protocol, complete remission was achieved in 24 cases (92%), partial remission was achieved in 1 case (4%), and disease relapse was found in 1 case (4%). Severe pulmonary infection occurred in 1 case in the course of treatment. The 2-year overall survival rate and event-free survival rate were 100% and 89.7% respectively. Conclusions Favorable histology is most common pathological type in children with WT. The chemotherapy based on the WT-2009 protocol for WT can produce a favorable prognosis and a high tolerance.
About author:: 10.7499/j.issn.1008-8830.2015.03.013
Cite this article:
GUO Xia,LIN Chao,GAO Ju et al. Efficacy and safety of the WT-2009 chemotherapy protocol in treatment of Wilms' tumor in children[J]. CJCP, 2015, 17(3): 262-265.
GUO Xia,LIN Chao,GAO Ju et al. Efficacy and safety of the WT-2009 chemotherapy protocol in treatment of Wilms' tumor in children[J]. CJCP, 2015, 17(3): 262-265.
Fukuzawa M. Treatment strategy for children with Wilms tumor[J]. Nihon Geka Gakkai Zasshi, 2005, 106(7): 422-426.
[3]
Pastore G, Znaor A, Spreadfico F, et al. Malignant renal tumors incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System Project[J]. Eur J Cancer, 2006, 42(13): 2103-2114.
Eble JN, Sauter G, Epstein JI, et al. Pathology and genetics of tumors of the urinary system and male genital organs[M]. Lyon France: IARC Press, 2004: 48-52.
[8]
Beckwith JB. National Wilms tumor study: an update for pathologists[J]. Pediatr Dev Pathol, 1998, 1(1): 79-84.
[9]
Dome JS, Cotton CA, Perlman EJ, et al. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study[J]. J Clin Oncol, 2006, 24(15): 2352-2358.
[10]
Cai JY, Pan C, Lu Q, et al. Childhood renal tumor: a report from a Chinese Children's Cancer Group[J]. Biomed Res Int, 2014, 2014: 894341.
[11]
Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada[J]. J Natl Cancer Inst, 2000, 92(3): 205-216.
Varan A. Wilms' tumor in children: an overview[J]. Nephron Clin Pract, 2008, 108(2): C83-C90.
[14]
Metzger ML, Dome JS. Current therapy for Wilms' tumor[J]. Oncologist, 2005, 10(10): 815-826.
[15]
Tournade MF, Com-Nougue C, de Kraker J, et al. Optimal duration of preoperation therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study[J]. J Clin Oncol, 2001, 19(2): 488-500.
[16]
Kalapurakal JA, Li SM, Breslow NE, et a1. Influence of radiation therapy delayon abdominal tumor recurrence in patients with favorable histology Wilms' tumor treated on NWTS-3 and NWTS-4: a report from the National Wilms' Tumor Study Group[J]. Int J Radiat Oncol Biol Phys, 2003, 57(2): 495-499.
[17]
Jereb B, Burgers M, Tournade M, et al. Radiotherapy in the SIOP[J]. Med Pediatr Oncol, 1994, 22(4): 221-227.
